Our research team develops nanotechnology tools to better understand cardiometabolic diseases such as atherosclerosis, type 2 diabetes, obesity, and Alzheimer’s. We engineer, make, and test drug delivery vehicles such as nanoparticles and viral gene delivery vectors that treat these conditions. In addition to drug delivery projects, our laboratory investigates lipoproteins and their function and metabolic biology of immune cells. We also have a long-standing interest in toxicology of synthetic and environmental nano-/microparticles and their effects on cardiometabolic health. Please navigate to our home page to discover projects we are working on, or click here.
We welcome you to our website and hope you enjoy reading about us, our science, and what inspires us! Please feel free to contact us if you have any questions and if you like to learn how to get involved!